Volume 18, Issue 4 (April 2020)                   IJRM 2020, 18(4): 235-242 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ali Z, Khaliq S, Zaki S, Ahmad H U, Lone K P. Comparative gene expression analysis of Fas and related genes in preeclamptic and healthy women: A cross-sectional study. IJRM 2020; 18 (4) :235-242
URL: http://ijrm.ir/article-1-1273-en.html
1- Department of Physiology and Cell Biology, University of Health Sciences Lahore, Lahore, Pakistan. , zaima.ali@hotmail.com
2- Department of Physiology and Cell Biology, University of Health Sciences Lahore, Lahore, Pakistan.
3- Department of Obstetrics and Gynecology, Jinnah Hospital Lahore, Lahore, Pakistan.
Full-Text [PDF 470 kb]   (764 Downloads)     |   Abstract (HTML)  (2161 Views)
Full-Text:   (533 Views)

 
1. Introduction
The outcome of a successful pregnancy is mainly dependent on placental sufficiency but any disorder resulting in poor placentation during pregnancy leads to preeclampsia (PE),restricted growth of the fetus and placental abruption (1, 2). PE is a gestational disorder,characterized by a rise in blood pressure and
proteinuria commencing at more than 20wk of gestational age. It contributes a large share to the burden of maternal morbidity and mortality with an overall incidence of 2-10% worldwide (3).
Normal placentation revolves around balanced angiogenesis and apoptosis. A number of studies have addressed disturbances in apoptosis in the placental bed in PE (4-6). Tumor necrosis factor alpha (TNF-𝛼) secreted by macrophages and monocytes can induce apoptosis in vascular smooth muscle cells surrounding the spiral arteries as well as human trophoblast in the placental bed (7). Trophoblast cells secret TNF-𝛼 and ischemia of the placenta results in increased release of this proinflammatory cytokine (8, 9). In normal pregnancy,there is a shift of maternal immune response from T helper 1 towards T helper 2 response (10). This
shift does not occurs in pregnancies complicated by PE with a resultant increase in the production of type 1 cytokines, e.g. TNF-𝛼, IL-2, and Interferon
gamma. All of these induce inflammation (11, 12).
Fas and FasL, members of TNF-𝛼 superfamily,are representative of the intrinsic pathway of apoptosis and are highly expressed on invasive extra-villous trophoblast cells as well as maternal lymphocytes. Abundant FasL expression on trophoblast was proclaimed to induce apoptosis of harmful activated maternal lymphocytes while the enhanced Fas expression on invasive trophoblast results in apoptotic death of these cells in the developing placenta (13). Many studies have reported the disturbance of the intrinsic pathway of apoptosis with differential expression of TNF-𝛼, Fas, and FasL in placental bed in pregnancies
complicated with PE and intrauterine growth retardation (IUGR) (5, 14, 15). The emerging concept that release of placental remains into maternal
blood modulates the gene expression of circulating blood cells has persuaded the researchers to study gene expression in circulating blood cells
(16). Moreover, cells outside the placental bed like macrophages and monocytes have been reported to produce TNF-𝛼 (7). We hypothesized that peripheral blood mononuclear cells (PBMCs) might contribute as an extra placental source of mRNA expression of TNF-𝛼, Fas, and FasL. Only preliminary data is available regarding this extra placental source (PBMCs) of these inflammatory and apoptotic mediators. The mRNA expression of these genes in PBMCs in PE has not been studied by real-time polymerase chain reaction (PCR) except for TNF-𝛼 (17). The selection of PBMCs as the experimental tissue using real-time PCR as the study method is novel regarding these three genes expression analysis in PE. To elucidate the role of mRNA expression of these genes, across-sectional comparative study was designed.
The aim of this study was to evaluate and compare the mRNA expression of TNF-𝛼, Fas, and FasL in maternal blood PBMCs in PE and healthy pregnancies in Pakistani women.
2. Materials and Methods 2.1. Sample collection The participants for this cross-sectional comparative study were collected from tertiary care hospital of Lahore from October 2016 to March 2017. Cases comprised of 18 pregnant women (between the ages of 18 and 40 yr) in the third trimester (28-40 wk), diagnosed as preeclamptic and 18 age-matched normal pregnant women at the same gestational age, considered as controls.
The criteria for PE were: new onset of systolic blood pressure >140 mmHg or diastolic blood pressure ≥90 mmHg at >20 wk of gestation accompanied
by 24 hr proteinuria ≥300 mg (≥1+ on dipstick),in at least two random urine samples collected 4-6 hr apart. Cases were further grouped into early-onset PE (EOP, 28-32 wk) and late-onset PE (LOP, 32.1-40 wk) with nine women in each group.
All the participants were non-smoker. Women with a history of diabetes mellitus, renal disease,arthritis, inflammatory bowel disease, chronic hypertension, cardiovascular illness (e.g. ischemic heart disease), or other chronic inflammatory disease were excluded. Demographic data were recorded along with complete medical, obstetric, and family history.
5 ml of venous blood was drawn and collected considering aseptic measures in EDTA-coated vacutainer. Buffy coat was separated by centrifugation and stored at -20°C within an hour of sample collection. Favor Prep total RNA Isolation Kit (Favorgen, Taiwan) was used for RNA extraction following the manufacturer’s
instructions. The concentrations of extracted RNA were measured using Nano-drop and stored at -80°C in RNase/DNase free water.
2.2. Quantitative real Time-PCR Two μg of total RNA of each sample was used to synthesize cDNA. RevertAid First-strand cDNA Synthesis kit (Thermo Scientific, USA) was used to synthesize cDNA following the manufacturer’s instructions. Gene expression was quantified for 18 cases and 18 controls using synthesized
cDNA and gene-specific-primers for Real-time PCR (Table I) on CFX 96 (Biorad, USA) using 2 X SYBR Green master mix (Fermentas, USA) according to the manufacturer’s instructions. All reactions were carried in 20 μl of the reaction mixture with 1 μl of cDNA, 8 μl of 2 X SYBR Green Real-Time PCR Master mix, 0.5 μl of forward and reverse primers, and RNase-free water (Fermentas, USA). Real-time-PCR protocol was 94°C for 4 min, followed by 30 cycles of 94°C for 30 sec, annealing at 60°C for 30 sec,and extension at 70°C for 42 sec in a thermal cycle followed by melt curve analysis. Samples were assayed in duplicate and three housekeeping genes were used for data normalization. Relative gene expression analysis was performed using the 2−ΔΔct method. Confirmation of the products of the expected size was done by electrophoresis on agarose gel (Figure 1).
Table I. Sequence of primers used for quantitative real-time PCR


























2.3. Ethical consideration
The study was performed in accordance with the ethical standards of the institutional ethical review (code: UHS/Education/126-16/2754) and
with the Declaration of Helsinki 1964 and its later amendments. Informed written consent was obtained from all individual participants included in
the study.
2.4. Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences, Version 22.0, Armonk, New York, USA (SPSS).
The clinical parameters were expressed as means ± SD (standard deviation). Expression of the studied genes was normalized against the mean
of three housekeeping genes, that is, GAPDH,β-actin, and 18srRNA. Shapiro Wilk test was used to check the normality of data. The mRNA expression was compared using fold change values between two groups by students t test and One-way ANOVA with post-hoc Tukey’s test for comparison between the multiple groups (EOP, LOP, and normotensive group). Differences in gene expressions were reported as fold change with SD. Pearson’s correlation was used to find the
relationship between the expressions of different genes. P ≤ 0.05 was considered statistically significant.
3. Results
3.1. Clinical characteristics
The study population consisted of 18 women with PE and 18 healthy normotensive controls.
Maternal ages of the participants were 28.2 ± 5 and 25.4 ± 3 for the case and control groups, respectively (p = 0.06). Similarly, the difference between the gestational age at the time of sampling in the case group (32.3 ± 3) was not significant from the controls (32.2 ± 3) (p =0.91).
3.2. Gene expression analysis
Gene expression between different groups was reported as fold change (Figures 2, 3). The PBMCs mRNA expressions of Fas, FasL and TNF-𝛼 were
significantly different between the case and control groups with a marked increase in the case group (p ≤ 0.001 for all). FasL showed a marked increase of 3.21-fold while the results for TNF-𝛼 and Fas were3.08 and 2.98-fold, respectively (Table II).
For a detailed analysis of gene expression, the participants in the case group was divided into two subgroups, EOP and LOP, depending upon the time of onset of the disease. The difference in the mRNA expression of all the studied genes was not significant between the two subgroups (TableII).
3.3. Correlations between TNF-𝛼, Fas, and FasL mRNA expression mRNA expression of TNF-𝛼 showed a positive correlation with Fas expression in the case group
calculated by Pearson’s correlation (Pearson’s rho 0.95, p < 0.001). Similarly, FasL was found to be positively correlated with TNF-𝛼 (Pearson’s rho
0.88, p < 0.001, Table III).








4. Discussion
This study has reported elevated mRNA expression of TNF-𝛼 and its family members Fas and FasL in PBMCs in pregnancies complicated with PE as compared to normal pregnancies.
The Fas-FasL, mediators of the intrinsic pathway of apoptosis, are deranged and show an incline in the expression in disorders characterized by disrupted
immune tolerance or enhanced inflammation.
Defective placentation with the disturbance in apoptosis in the placental bed has been wellstudied.
Researchers have reported differential Fas and Fas ligand expression in trophoblast in PE (5, 18). In 2011 Tomas and colleagues showed a disturbance of these with a decline in expression of FasL in the villous trophoblast in pregnancies complicated with PE (5). In contrast, Nishizawa and co-workers found an increase in FasL expression but no difference in Fas expression in placental tissue in PE and normal pregnancies (18).
In addition to trophoblast, Fas and FasL pathway is expressed and used by maternal lymphocytes.
Altered expression of Fas has been reported in the lymphocytes in PE with a decrease in peripheral Gamma Delta T cells (γδ) and decidual Natural
killer (NK) cells (19). This decrease in the expression of Fas suggests decreased susceptibility of these cells to apoptosis, increasing the possibility of their
contribution to the pathogenesis of preeclampsia (19). Moreover, utero placental ischemia results in excessive shedding of syncytiotrophoblast micro particles into the maternal circulation in PE. These syncytiotrophoblast micro particles (STBM) accentuate the systemic inflammation by enhancing the expression of proinflammatory cytokines by PBMCs, enlightening their role in the widespread inflammation (12). We hypothesized that the Fas and FasL pathway is altered in the PBMCs in PE and reported an increase in mRNA expression of both Fas and FasL. In contrast, Kuntz and colleagues have reported a decrease
in surface expression of these two genes on leukocytes and lymphocytes in PE (20). The variation in the results could be attributed to the difference in the time of sample collection.
In our study sample collection was done in the third trimester while they took the samples after delivery. The levels of different inflammatory markers change from late pregnancy to the postpartum period (21).
Defective placentation in PE results in oxidative stress and increased production of proinflammatory TNF-𝛼 with resultant activation4. Discussion
This study has reported elevated mRNA expression of TNF-𝛼 and its family members Fas and FasL in PBMCs in pregnancies complicated with PE as compared to normal pregnancies.
The Fas-FasL, mediators of the intrinsic pathway of apoptosis, are deranged and show an incline in the expression in disorders characterized by disrupted
immune tolerance or enhanced inflammation.
Defective placentation with the disturbance in apoptosis in the placental bed has been wellstudied.
Researchers have reported differential Fas and Fas ligand expression in trophoblast in PE (5, 18). In 2011 Tomas and colleagues showed a disturbance of these with a decline in expression of FasL in the villous trophoblast in pregnancies complicated with PE (5). In contrast, Nishizawa and co-workers found an increase in FasL expression but no difference in Fas expression in placental tissue in PE and normal pregnancies (18).
In addition to trophoblast, Fas and FasL pathway is expressed and used by maternal lymphocytes.
Altered expression of Fas has been reported in the lymphocytes in PE with a decrease in peripheral Gamma Delta T cells (γδ) and decidual Natural
killer (NK) cells (19). This decrease in the expression of Fas suggests decreased susceptibility of these cells to apoptosis, increasing the possibility of their
contribution to the pathogenesis of preeclampsia (19). Moreover, utero placental ischemia results in excessive shedding of syncytiotrophoblast micro particles into the maternal circulation in PE. These syncytiotrophoblast micro particles (STBM) accentuate the systemic inflammation by enhancing the expression of proinflammatory cytokines by PBMCs, enlightening their role in the widespread inflammation (12). We hypothesized that the Fas and FasL pathway is altered in the PBMCs in PE and reported an increase in mRNA expression of both Fas and FasL. In contrast,Kuntz and colleagues have reported a decrease in surface expression of these two genes on leukocytes and lymphocytes in PE (20). The variation in the results could be attributed to the difference in the time of sample collection.
In our study sample collection was done in the third trimester while they took the samples after delivery. The levels of different inflammatory markers change from late pregnancy to the postpartum period (21).
Defective placentation in PE results in oxidative stress and increased production of proinflammatory TNF-𝛼 with resultant activation 4. Discussion
This study has reported elevated mRNA expression of TNF-𝛼 and its family members Fas and FasL in PBMCs in pregnancies complicated with PE as compared to normal pregnancies.
The Fas-FasL, mediators of the intrinsic pathway of apoptosis, are deranged and show an incline in the expression in disorders characterized by disrupted
immune tolerance or enhanced inflammation.
Defective placentation with the disturbance in apoptosis in the placental bed has been wellstudied.
Researchers have reported differential Fas and Fas ligand expression in trophoblast in PE (5, 18). In 2011 Tomas and colleagues showed a disturbance of these with a decline in expression of FasL in the villous trophoblast in pregnancies complicated with PE (5). In contrast, Nishizawa and co-workers found an increase in FasL expression but no difference in Fas expression in placental tissue in PE and normal pregnancies (18).
In addition to trophoblast, Fas and FasL pathway is expressed and used by maternal lymphocytes.
Altered expression of Fas has been reported in the lymphocytes in PE with a decrease in peripheral Gamma Delta T cells (γδ) and decidual Natural killer (NK) cells (19). This decrease in the expression of Fas suggests decreased susceptibility of these cells to apoptosis, increasing the possibility of their contribution to the pathogenesis of preeclampsia (19). Moreover, utero placental ischemia results in excessive shedding of syncytiotrophoblast micro particles into the maternal circulation in PE. These syncytiotrophoblast micro particles (STBM) accentuate the systemic inflammation by enhancing the expression of proinflammatory
cytokines by PBMCs, enlightening their role in the widespread inflammation (12). We hypothesized that the Fas and FasL pathway is altered in the PBMCs in PE and reported an increase in mRNA expression of both Fas and FasL. In contrast, Kuntz and colleagues have reported a decrease in surface expression of these two genes on leukocytes and lymphocytes in PE (20). The variation in the results could be attributed to the difference in the time of sample collection.
In our study sample collection was done in the third trimester while they took the samples after delivery. The levels of different inflammatory markers change from late pregnancy to the postpartum period (21).
Defective placentation in PE results in oxidative stress and increased production of proinflammatory TNF-𝛼 with resultant activation 4. Discussion
This study has reported elevated mRNA expression of TNF-𝛼 and its family members Fas and FasL in PBMCs in pregnancies complicated with PE as compared to normal pregnancies.
The Fas-FasL, mediators of the intrinsic pathway of apoptosis, are deranged and show an incline in the expression in disorders characterized by disrupted
immune tolerance or enhanced inflammation.
Defective placentation with the disturbance in apoptosis in the placental bed has been wellstudied.
Researchers have reported differential Fas and Fas ligand expression in trophoblast in PE (5, 18). In 2011 Tomas and colleagues showed a disturbance of these with a decline in expression of FasL in the villous trophoblast in pregnancies complicated with PE (5). In contrast, Nishizawa and co-workers found an increase in FasL expression but no difference in Fas expression in placental tissue in PE and normal pregnancies (18).
In addition to trophoblast, Fas and FasL pathway is expressed and used by maternal lymphocytes.
Altered expression of Fas has been reported in the lymphocytes in PE with a decrease in peripheral Gamma Delta T cells (γδ) and decidual Natural killer (NK) cells (19). This decrease in the expression of Fas suggests decreased susceptibility of these cells to apoptosis, increasing the possibility of their contribution to the pathogenesis of preeclampsia (19). Moreover, utero placental ischemia results in excessive shedding of syncytiotrophoblast micro particles into the maternal circulation in PE. These syncytiotrophoblast micro particles (STBM) accentuate the systemic inflammation by enhancing the expression of proinflammatory
cytokines by PBMCs, enlightening their role in the widespread inflammation (12). We hypothesized that the Fas and FasL pathway is altered in the
PBMCs in PE and reported an increase in mRNA expression of both Fas and FasL. In contrast,Kuntz and colleagues have reported a decrease in surface expression of these two genes on leukocytes and lymphocytes in PE (20). The variation in the results could be attributed to the difference in the time of sample collection.
In our study sample collection was done in the third trimester while they took the samples after delivery. The levels of different inflammatory markers change from late pregnancy to the postpartum period (21).
Defective placentation in PE results in oxidative stress and increased production of proinflammatory TNF-𝛼 with resultant activation
Type of Study: Original Article | Subject: Reproductive Biology

References
1. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204: 193-201. [DOI:10.1016/j.ajog.2010.08.009]
2. Romero R, Kusanovic JP, Chaiworapongsa T, Hassan SS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol 2011; 25: 313-327. [DOI:10.1016/j.bpobgyn.2011.02.006]
3. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-474. [DOI:10.2147/VHRM.S20181]
4. Can M, Guven B, Bektas S, Arikan I. Oxidative stress and apoptosis in preeclampsia. Tissue Cell 2014; 46: 477-481. [DOI:10.1016/j.tice.2014.08.004]
5. Tomas SZ, Prusac IK, Roje D, Tadin I. Trophoblast apoptosis in placentas from pregnancies complicated by preeclampsia. Gynecol Obstet Invest 2011; 71: 250-255. [DOI:10.1159/000320289]
6. Barakonyi A, Miko E, Szereday L, Polgar PD, Nemeth T, Szekeres-Bartho J, et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia. Reprod Sci 2014; 21: 155-166. [DOI:10.1177/1933719113497288]
7. Boyle JJ, Weissberg PL, Bennett MR. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol 2003; 23: 1553-1558. [DOI:10.1161/01.ATV.0000086961.44581.B7]
8. Cackovic M, Buhimschi CS, Zhao G, Funai EF, Norwitz ER, Kuczynski E, et al. Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet Gynecol 2008; 112: 93-100. [DOI:10.1097/AOG.0b013e31817c4304]
9. Zhou P, Luo X, Qi HB, Zong WJ, Zhang H, Liu DD, et al. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res 2012; 61: 1005-1012. [DOI:10.1007/s00011-012-0507-x]
10. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009; 174: 1959-1971. [DOI:10.2353/ajpath.2009.080995]
11. Mihu D, Razvan C, Malutan A, Mihaela C. Evaluation of maternal systemic inflammatory response in preeclampsia. Taiwan J Obstet Gynecol 2015; 54: 160-166. [DOI:10.1016/j.tjog.2014.03.006]
12. Germain SJ, Sacks GP, Soorana SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178: 5949-5956. [DOI:10.4049/jimmunol.178.9.5949]
13. Kauma SW, Huff TF, Hayes N, Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999; 84: 2188-2194. [DOI:10.1210/jc.84.6.2188]
14. Resic Karara J, Zekic Tomas S, Marusic J, Roje D, Kuzmic Prusac I. Fas and FasL expression in placentas complicated with intrauterine growth retardation with and without preeclampsia. J Matern Fetal Neonatal Med 2016; 29: 1154-1159. [DOI:10.3109/14767058.2015.1038702]
15. Prusac IK, Zekic Tomas S, Roje D. Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia. Acta Obstet Gynecol Scand 2011; 90: 1157-1163. [DOI:10.1111/j.1600-0412.2011.01152.x]
16. Martinez-Fierro ML, Garza-Veloz I, Carrillo-Sanchez K, Martinez-Gaytan V, Cortes-Flores R, Ochoa-Torres MA, et al. Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia. Hypertens Pregnancy 2014; 33: 191-203. [DOI:10.3109/10641955.2013.853777]
17. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154-159. [DOI:10.1046/j.1365-2249.1996.d01-647.x]
18. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H, et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011; 9: 107-118. [DOI:10.1186/1477-7827-9-107]
19. Barakonyi A, Miko E, Szereday L, Polgar PD, Nemeth T, Szekeres-Bartho J, et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia. Reprod Sci 2014; 21: 155-166. [DOI:10.1177/1933719113497288]
20. Kuntz TB, Christensen RD, Stegner J, Duff P, Koenig JM. Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia. Pediatr Res 2001; 50: 743-749. [DOI:10.1203/00006450-200112000-00019]
21. Bränn E, Edvinsson Å, Rostedt Punga A, Sundström-Poromaa I, Skalkidou A. Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum. Sci Rep 2019; 9: 1863-1872. [DOI:10.1038/s41598-018-38304-w]
22. Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract 2013; 22 (Suppl.): 8-19. [DOI:10.1159/000354200]
23. Pinheiro MB, Martins-Filho OA, Mota AP, Alpoim PN, Godoi LC, Silveira AC, et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine 2013; 62: 165-173. [DOI:10.1016/j.cyto.2013.02.027]
24. Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, et al. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PloS One 2014; 9: e97632. [DOI:10.1371/journal.pone.0097632]
25. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-2512. [DOI:10.1210/jc.86.6.2505]
26. Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 1990; 171: 2025-2041. [DOI:10.1084/jem.171.6.2025]
27. Fluhr H, Krenzer S, Stein GM, Stork B, Deperschmidt M, Wallwiener D, et al. Interferon-γ and tumor necrosis factor-α sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. J Cell Sci 2007; 120: 4126-4133. [DOI:10.1242/jcs.009761]
28. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002; 66: 1853-1861. [DOI:10.1095/biolreprod66.6.1853]
29. Neale D, Demasio K, Illuzi J, Chaiworapongsa T, Romero R, Mor G. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med 2003; 13: 39-44. [DOI:10.1080/jmf.13.1.39.44]
30. Dagdelen M, Temur M, Yılmaz Ö, Altındag T, Uslu T, Özbay PÖ. Placental bed apoptosis is increased in pregnant women with pre-eclampsia versus normotensive pregnant women. J Obstet Gynaecol 2016; 36: 974-979. [DOI:10.1080/01443615.2016.1178221]
31. Mendilcioglu I, Karaveli S, Erdogan G, Simsek M, Taskin O, Ozekinci M. Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia. Clin Exp Obstet Gynecol 2011; 38: 38-42.
32. Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM. Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. Placenta 2012; 33: 352-359. [DOI:10.1016/j.placenta.2012.01.017]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb